Sign In

Login

Password

Forgot Password ? Sign Up

Sistema oral de liberação osmótica (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sistema oral de liberação osmótica" in Portuguese language version.

refsWebsite
Global rank Portuguese rank
13nih.gov
4th place
8th place
13doi.org
2nd place
4th place
1harvard.edu
18th place
51st place
1google.com
163rd place
204th place

doi.org

dx.doi.org

  • «Oral osmotically driven systems: 30 years of development and clinical use.». European Journal of Pharmaceutics and Biopharmaceutics. 73: 311–23. PMID 19602438. doi:10.1016/j.ejpb.2009.07.002 
  • «Systems for triggered, pulsed, and programmed drug delivery.». Annals of the New York Academy of Sciences. 618: 428–40. Bibcode:1991NYASA.618..428T. PMID 2006800. doi:10.1111/j.1749-6632.1991.tb27262.x 
  • «Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form.». Current Medical Research and Opinion. 22: 1879–92. PMID 17022845. doi:10.1185/030079906x132613 
  • Gupta, BP; Thakur, N; Jain, NP; Banweer, J; Jain, S (2010). «Osmotically controlled drug delivery system with associated drugs.». Journal of Pharmacy & Pharmaceutical Sciences. 13: 571–88. PMID 21486532. doi:10.18433/j38w25 
  • Verma, RK; Mishra, B; Garg, S (1 de julho de 2000). «Osmotically controlled oral drug delivery.». Drug Development and Industrial Pharmacy. 26: 695–708. PMID 10872087. doi:10.1081/ddc-100101287 
  • van den Berg, G; van Steveninck, F; Gubbens-Stibbe, JM; Schoemaker, HC; de Boer, AG; Cohen, AF (1990). «Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.». European Journal of Clinical Pharmacology. 39: 315–6. PMID 2257873. doi:10.1007/bf00315121 
  • Bass, DM; Prevo, M; Waxman, DS (2002). «Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.». Drug Safety. 25: 1021–33. PMID 12408733. doi:10.2165/00002018-200225140-00004 
  • Modi, NB; Wang, B; Hu, WT; Gupta, SK (1 de janeiro de 2000). «Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects.». Biopharmaceutics & Drug Disposition. 21: 23–31. PMID 11038435. doi:10.1002/1099-081x(200001)21:1<23::aid-bdd212>3.0.co;2-v 
  • Auiler, JF; Liu, K; Lynch, JM; Gelotte, CK (2002). «Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study.». Current Medical Research and Opinion. 18: 311–6. PMID 12240794. doi:10.1185/030079902125000840 
  • Theeuwes, F (1975). «Elementary osmotic pump.». Journal of Pharmaceutical Sciences. 64: 1987–91. PMID 1510. doi:10.1002/jps.2600641218 
  • Eckenhoff, B; Yum, SI (1981). «The osmotic pump: novel research tool for optimizing drug regimens.». Biomaterials. 2: 89–97. PMID 7248427. doi:10.1016/0142-9612(81)90005-3 
  • Heimlich, KR (1983). «The evolution of precision drug delivery.». Current Medical Research and Opinion. 8 Suppl 2: 28–37. PMID 6851623. doi:10.1185/03007998309109821 
  • Swanson, J; Gupta, S; Lam, A; Shoulson, I; Lerner, M; Modi, N; Lindemulder, E; Wigal, S (fevereiro de 2003). «Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies.». Archives of General Psychiatry. 60: 204–11. PMID 12578439. doi:10.1001/archpsyc.60.2.204 

google.com

harvard.edu

ui.adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

  • «Oral osmotically driven systems: 30 years of development and clinical use.». European Journal of Pharmaceutics and Biopharmaceutics. 73: 311–23. PMID 19602438. doi:10.1016/j.ejpb.2009.07.002 
  • «Systems for triggered, pulsed, and programmed drug delivery.». Annals of the New York Academy of Sciences. 618: 428–40. Bibcode:1991NYASA.618..428T. PMID 2006800. doi:10.1111/j.1749-6632.1991.tb27262.x 
  • «Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form.». Current Medical Research and Opinion. 22: 1879–92. PMID 17022845. doi:10.1185/030079906x132613 
  • Gupta, BP; Thakur, N; Jain, NP; Banweer, J; Jain, S (2010). «Osmotically controlled drug delivery system with associated drugs.». Journal of Pharmacy & Pharmaceutical Sciences. 13: 571–88. PMID 21486532. doi:10.18433/j38w25 
  • Verma, RK; Mishra, B; Garg, S (1 de julho de 2000). «Osmotically controlled oral drug delivery.». Drug Development and Industrial Pharmacy. 26: 695–708. PMID 10872087. doi:10.1081/ddc-100101287 
  • van den Berg, G; van Steveninck, F; Gubbens-Stibbe, JM; Schoemaker, HC; de Boer, AG; Cohen, AF (1990). «Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.». European Journal of Clinical Pharmacology. 39: 315–6. PMID 2257873. doi:10.1007/bf00315121 
  • Bass, DM; Prevo, M; Waxman, DS (2002). «Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.». Drug Safety. 25: 1021–33. PMID 12408733. doi:10.2165/00002018-200225140-00004 
  • Modi, NB; Wang, B; Hu, WT; Gupta, SK (1 de janeiro de 2000). «Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects.». Biopharmaceutics & Drug Disposition. 21: 23–31. PMID 11038435. doi:10.1002/1099-081x(200001)21:1<23::aid-bdd212>3.0.co;2-v 
  • Auiler, JF; Liu, K; Lynch, JM; Gelotte, CK (2002). «Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study.». Current Medical Research and Opinion. 18: 311–6. PMID 12240794. doi:10.1185/030079902125000840 
  • Theeuwes, F (1975). «Elementary osmotic pump.». Journal of Pharmaceutical Sciences. 64: 1987–91. PMID 1510. doi:10.1002/jps.2600641218 
  • Eckenhoff, B; Yum, SI (1981). «The osmotic pump: novel research tool for optimizing drug regimens.». Biomaterials. 2: 89–97. PMID 7248427. doi:10.1016/0142-9612(81)90005-3 
  • Heimlich, KR (1983). «The evolution of precision drug delivery.». Current Medical Research and Opinion. 8 Suppl 2: 28–37. PMID 6851623. doi:10.1185/03007998309109821 
  • Swanson, J; Gupta, S; Lam, A; Shoulson, I; Lerner, M; Modi, N; Lindemulder, E; Wigal, S (fevereiro de 2003). «Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies.». Archives of General Psychiatry. 60: 204–11. PMID 12578439. doi:10.1001/archpsyc.60.2.204